# Comprehensive Assessment of Multiple Products (CAMP)

> **NCT07276347** · NA · COMPLETED · sponsor: **CooperVision International Limited (CVIL)** · enrollment: 36 (actual)

## Conditions studied

- Hyperopia
- Myopia

## Interventions

- **DEVICE:** somofilcon A lens
- **DEVICE:** stenfilcon A lens
- **DEVICE:** fanfilcon A lens
- **DEVICE:** comfilcon A lens
- **DEVICE:** verofilcon A lens
- **DEVICE:** serafilcon A lens
- **DEVICE:** lehfilcon A lens
- **DEVICE:** delefilcon A lens
- **DEVICE:** senofilcon A daily disposable lens
- **DEVICE:** senofilcon A with blue light technology lens
- **DEVICE:** senofilcon A bi-weekly lens
- **DEVICE:** samfilcon A lens
- **DEVICE:** kalilfilcon A lens

## Key facts

- **NCT ID:** NCT07276347
- **Lead sponsor:** CooperVision International Limited (CVIL)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-12
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276347, "Comprehensive Assessment of Multiple Products (CAMP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07276347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*